Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Despite no proven benefits for patients with ovarian cancer in remission, CT-scans and cancer antigen 125 (CA-125) tests are still being routinely used in ovarian cancer surveillance, according to ... Read more
Researchers at the Wistar Institute identified a new protein that is expressed on the surface of different types of ovarian cancer cells. This protein can therefore be targeted to ... Read more
Pin It on Pinterest